Spina bifida is a relatively common, structural malformation that is associated with excess morbidity and mortality. A specific etiologic agent(s) cannot be identified in the majority of individuals with spina bifida, and in this group of patients the condition is believed to be a genetically complex trait. As with other complex human traits, spina bifida is thought to be influenced by common genetic variants that, individually, may have only a small to moderate effect on risk. Our funded study is designed to address the hypothesis that common variants in folate-related genes contribute to the risk of spina bifida. Our evaluation of this hypothesis considers the roles played by both the maternal and embryonic genotype, and the possibility that the interplay of genes and environmental risk factors may be more relevant to the risk of spina bifida than is the independent main effect of any one susceptibility locus. In this investigator-initiated, revision application, we propose to: (1) change the method used for the collection of samples for DNA extraction (from buccal brushes to saliva) for newly enrolled subjects, and (2) add the collection of a saliva sample from enrolled study subjects who previously provided a buccal brush sample. These revisions will enhance our ability to achieve the immediate and long- term goals of our research program, by providing an improved source of DNA (relative to buccal brushes) for our current and future investigations. Specifically, improvement in DNA quality will result in decreased measurement error (i.e. decreased genotyping errors, which can lead to differential bias in family-based studies) and improved genotyping call rates (i.e. less missing data), which will have a positive impact on the validity and precision of our study findings. Further, improved DNA yield will allow us to take advantage of high-density genotyping platforms, which offer both cost and time efficiency, and will enhance the long-term, scientific usefulness of our DNA bank.

Public Health Relevance

Neural tube defects, including spina bifida, are common, serious birth defect that affects approximately 324,000 births worldwide (1) and 3,000 pregnancies in the United States annually. Our funded study will provide important information regarding the factors that influence the risk of spina bifida that, ultimately, will allow for more accurate genetic counseling and improved methods for preventing this condition. The proposed revisions to the funded study, which are aimed at increasing the quantity and quality of the DNA available for our investigations, will improve the likelihood that the study goals will be realized. ? ? ?

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
3R01HD039195-08S1
Application #
7457100
Study Section
Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section (IRAP)
Program Officer
Henken, Deborah B
Project Start
2000-09-01
Project End
2011-02-28
Budget Start
2008-03-25
Budget End
2009-02-28
Support Year
8
Fiscal Year
2008
Total Cost
$160,437
Indirect Cost
Name
Texas A&M University
Department
Genetics
Type
Schools of Medicine
DUNS #
835607441
City
College Station
State
TX
Country
United States
Zip Code
77845
Agopian, A J; Bhalla, Angela D; Boerwinkle, Eric et al. (2013) Exon sequencing of PAX3 and T (brachyury) in cases with spina bifida. Birth Defects Res A Clin Mol Teratol 97:597-601
Agopian, A J; Eastcott, Lisa M; Mitchell, Laura E (2012) Age of onset and effect size in genome-wide association studies. Birth Defects Res A Clin Mol Teratol 94:908-11
Summers, Carolyn M; Mitchell, Laura E; Stanislawska-Sachadyn, Anna et al. (2010) Genetic and lifestyle variables associated with homocysteine concentrations and the distribution of folate derivatives in healthy premenopausal women. Birth Defects Res A Clin Mol Teratol 88:679-88
Stanislawska-Sachadyn, A; Woodside, J V; Sayers, C M et al. (2010) The transcobalamin (TCN2) 776C>G polymorphism affects homocysteine concentrations among subjects with low vitamin B(12) status. Eur J Clin Nutr 64:1338-43
Hammons, Andrea L; Summers, Carolyn M; Woodside, Jayne V et al. (2009) Folate/homocysteine phenotypes and MTHFR 677C>T genotypes are associated with serum levels of monocyte chemoattractant protein-1. Clin Immunol 133:132-7
Mitchell, Laura E; Morales, Megan; Khartulyari, Stefanie et al. (2009) Folate and homocysteine phenotypes: Comparative findings using research and clinical laboratory data. Clin Biochem 42:1275-81
Lu, Zhi-Yong; Jensen, Liselotte E; Huang, Yuehua et al. (2009) The up-regulation of monocyte chemoattractant protein-1 (MCP-1) in Ea.hy 926 endothelial cells under long-term low folate stress is mediated by the p38 MAPK pathway. Atherosclerosis 205:48-54
Lu, Zhi-Yong; Morales, Megan; Khartulyari, Stephanie et al. (2008) Genetic and biochemical determinants of serum concentrations of monocyte chemoattractant protein-1, a potential neural tube defect risk factor. Birth Defects Res A Clin Mol Teratol 82:736-41
Summers, Carolyn M; Hammons, Andrea L; Mitchell, Laura E et al. (2008) Influence of the cystathionine beta-synthase 844ins68 and methylenetetrahydrofolate reductase 677C>T polymorphisms on folate and homocysteine concentrations. Eur J Hum Genet 16:1010-3
Stanislawska-Sachadyn, Anna; Woodside, Jayne V; Brown, Karen S et al. (2008) Evidence for sex differences in the determinants of homocysteine concentrations. Mol Genet Metab 93:355-62

Showing the most recent 10 out of 32 publications